Benjamin F. Edwards & Company, Inc. Illumina, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$183.43 - $232.67 $132,986 - $168,685	-725 Reduced 98.77%	9 $2,000
Q1 2023 Apr 27, 2023	SELL	$193.75 - $232.55 $21,700 - $26,045	-112 Reduced 13.24%	734 $171,000
Q4 2022 Feb 07, 2023	SELL	$187.24 - $242.74 $79,764 - $103,407	-426 Reduced 33.49%	846 $171,000
Q3 2022 Oct 28, 2022	BUY	$177.23 - $227.44 $4,962 - $6,368	28 Added 2.25%	1,272 $243,000
Q2 2022 Aug 12, 2022	BUY	$181.58 - $368.0 $726 - $1,472	4 Added 0.32%	1,244 $229,000
Q1 2022 May 04, 2022	BUY	$303.87 - $423.8 $101,188 - $141,125	333 Added 36.71%	1,240 $433,000
Q4 2021 Feb 07, 2022	BUY	$347.28 - $421.83 $219,828 - $267,018	633 Added 231.02%	907 $345,000
Q1 2021 May 14, 2021	BUY	$361.28 - $504.76 $39,740 - $55,523	110 Added 67.07%	274 $105,000
Q4 2020 Feb 16, 2021	SELL	$292.7 - $370.96 $1,756 - $2,225	-6 Reduced 3.53%	164 $61,000
Q3 2020 Nov 13, 2020	BUY	$268.51 - $400.74 $1,342 - $2,003	5 Added 3.03%	170 $53,000
Q1 2020 May 07, 2020	SELL	$209.2 - $335.53 $51,044 - $81,869	-244 Reduced 59.66%	165 $45,000
Q3 2019 Nov 05, 2019	SELL	$266.84 - $378.23 $30,152 - $42,739	-113 Reduced 21.65%	409 $124,000
Q2 2019 Aug 08, 2019	BUY	$300.59 - $368.15 $16,833 - $20,616	56 Added 12.02%	522 $192,000
Q3 2018 Oct 29, 2018	SELL	$279.04 - $367.06 $2,790 - $3,670	-10 Reduced 2.1%	466 $171,000
Q2 2018 Jul 19, 2018	BUY	$228.17 - $292.07 $10,952 - $14,019	48 Added 11.21%	476 $133,000
Q1 2018 Apr 17, 2018	BUY	$209.54 - $253.91 $5,028 - $6,093	24 Added 5.94%	428 $101,000
Q4 2017 Jan 17, 2018	BUY	$202.23 - $230.03 $4,044 - $4,600	20 Added 5.21%	404 $88,000
Q3 2017 Oct 24, 2017	BUY	$172.3 - $213.93 $66,163 - $82,149	384	384 $76,000

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account